Product Display

產品介绍

02

Brain Rhabilitation

Brain Rhabilitation

Brain Rhabilitation

阿尔茨海默癥

Technical background

技術背景

The brain of Alzheimer's patients includes at least nine types of lesions

  • Amyloid protein

    Amyloid beta accumulates in the brain Causing amyloid plateau and leading to neurotoxicity in the brain

  • Tau protein

    Accumulation of tau eggs, also known as neurofibrillary tangles, causes another type of brain neurotoxicity

  • ATP

    ATP (energy source) reduction And lead to brain energy failure

  • Autophagy ability

    Deposition of beta amyloid and tau proteins in cells caused by impaired autophagy function (cell waste clearance function)

  • Inflammation

    Elevated levels of IL-6 (inflammatory factor)

  • P53

    P53 (Disease Control Gene) Dysfunction

  • SOD

    SOD (used to reduce basal) dysfunction, Causing the accumulation of free radicals in the brain

  • NF-KB(P65)

    Neuroinflammation caused by NF kB (p65)

  • TNF-a

    Elevated TNF alpha (inflammatory factor)

The causes of diseases

Alzheimer's disease is a multifactorial neurodegenerative disease, and its etiology includes multiple factors. Due to the complexity of this disease, effective therapeutic drugs have not yet been found in humans

The brain of Alzheimer's patients includes at least nine types of lesions: 1. Amyloid beta accumulates in the brain, causing amyloid plaques and leading to neurotoxicity in the brain
2. Tau accumulation, also known as nerve fiber entanglement. Causing another type of brain neurotoxicity
3. Neuroinflammation caused by NF kB (p65)
4. ATP (energy source) decreases and leads to brain energy failure
5. Cell beta amyloid and tau egg deposition caused by impaired autophagy function (cell waste clearance function)
6. IL-6 (inflammatory factor) rises
7. TNF alpha (inflammatory factor) increases
(8) P53 (disease control gene) dysfunction
(9) SOD (to reduce free radical) dysfunction, causing free radicals to accumulate in the brain
Due to the multiple etiological factors of Alzheimer's disease, the previous use of drugs targeting individual symptoms may not be effective for patients, leading to the failure of many recent clinical trials of new drugs targeting Alzheimer's disease.

Brain Rhabilitation

Brain Rhabilitation

Brain Rhabilitation

This mixture is a concentrated essence oral liquid with excellent stability, which does not undergo cross-linking reactions, Maillard reactions, or condensation reactions< br> Loose storage, transportation, and usage conditions, as well as a large temperature and humidity range< Suitable for all affected populations, with no risk of religious beliefs


Product price:2288 RMB
Product specifications:4X5 20 tubes/box
Usage:Twist open the bottle cap and take directly, twice a day. Overdose is strictly prohibited
This is suitable for:Early stage Alzheimer's patients

Product efficacy

  • Repair brain cell DNA and enhance autophagy in brain cells

  • Supplementing protein and myelin, enhancing cognitive ability, stabilizing emotions

  • Helps maintain the integrity and connectivity of brain cells, preventing Alzheimer's disease

  • Helps promote healthy inflammatory responses and supports brain health

Patent certificate

專利證書